Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
| |
Authors: | Beaton Melanie D |
| |
Affiliation: | Department of Medicine, Unversity of Western Ontario, London, Ontario, Canada. melanie.beaton@lhsc.on.ca |
| |
Abstract: | Nonalcoholic fatty liver disease is the leading cause of liver disease in western society. It is a cause of end-stage liver disease, with increased mortality secondary to cirrhosis and its complications. It is also recognized that cardiovascular disease is a significant cause of death in these patients. Significant work evaluating various treatments has been performed in recent years; however, to date, no ideal therapy exists. Lifestyle modification remains the cornerstone of management. The present article reviews the current status of various treatment modalities evaluated in nonalcoholic fatty liver disease. |
| |
Keywords: | Fibrosis Hepatic steatosis Metabolic syndrome Treatment |
本文献已被 PubMed 等数据库收录! |
|